Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
企業コードKVUE
会社名Kenvue Inc
上場日May 04, 2023
最高経営責任者「CEO」Mr. Kirk L. Perry
従業員数22000
証券種類Ordinary Share
決算期末May 04
本社所在地1 Kenvue Way
都市SUMMIT
証券取引所NYSE Consolidated
国United States of America
郵便番号07901
電話番号19088741200
ウェブサイトhttps://www.kenvue.com
企業コードKVUE
上場日May 04, 2023
最高経営責任者「CEO」Mr. Kirk L. Perry
過去5年間の配当金総支払額は
2.32B
米ドルである。
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023